EXJADE

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug EXJADE contains one active pharmaceutical ingredient (API):

1	Deferasirox UNII V8G4MOF2V9 - DEFERASIROX
	Deferasirox is an orally active chelator that is highly selective for iron (III). It is a tridentate ligand that binds iron with high affinity in a 2:1 ratio. Deferasirox promotes excretion of iron, primarily in the faeces.
	Read more about Deferasirox

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EXJADE Dispersible tablet	MPI, EU: SmPC	European Medicines Agency (EU)
EXJADE Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)
EXJADE Granules in sachet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V03AC03	Deferasirox	V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AC Iron chelating agents
Discover more medicines within V03AC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	526526801110217, 526526802117215, 526526803113213
CA	Health Products and Food Branch	02287420, 02287439, 02287447
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.265-09-06
EE	Ravimiamet	1258624, 1258635, 1258646, 1258657, 1258668, 1258679, 1410499, 1410501, 1410512, 1693795, 1713923, 1713934, 1713945, 1713956, 1713967, 1713978, 1713989, 1713990, 1714003, 1755817, 1755828, 1755839, 1777934
ES	Centro de información online de medicamentos de la AEMPS	106356011, 106356017
FI	Lääkealan turvallisuus- ja kehittämiskeskus	084182, 381794, 395077
FR	Base de données publique des médicaments	63404789, 65539020, 67055858
GB	Medicines & Healthcare Products Regulatory Agency	336219, 336222, 336225
HK	Department of Health Drug Office	54547, 54548, 54549
IE	Health Products Regulatory Authority	88687, 88688, 88689
IL	מִשְׂרַד הַבְּרִיאוּת	4925, 4926, 4927
IT	Agenzia del Farmaco	037421118, 037421144, 037421171
LT	Valstybinė vaistų kontrolės tarnyba	1028091, 1028092, 1028093, 1028094, 1028095, 1028096, 1056579, 1056580, 1056581, 1076652, 1080007, 1080008, 1080009, 1080010, 1080011, 1080012, 1080013, 1080014, 1080015, 1084436, 1084437, 1084438
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	192M2006
NL	Z-Index G-Standaard, PRK	137189, 137197, 137200, 81736, 81744, 81752
NZ	Medicines and Medical Devices Safety Authority	12113, 12114, 12115
PL	Rejestru Produktów Leczniczych	100135197, 100135375, 100136245, 100372402, 100372425, 100372431, 100397738, 100397744, 100397750
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64440001, W64440002, W64440003, W64441001, W64441002, W64441003, W64442001, W64442002, W64442003, W64443001, W64443002, W64443003, W64444001, W64444002, W64444003
SG	Health Sciences Authority	13393P, 13394P, 13395P
TN	Direction de la Pharmacie et du Médicament	10283251H, 10283252H, 10283253H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699504070019, 8699504070026, 8699504070033
US	FDA, National Drug Code	0078-0468, 0078-0469, 0078-0470
ZA	Health Products Regulatory Authority	A40/27/0266, A40/27/0267, A40/27/0268